top of page

Thinking Differently

MBOS_Style9+Outline+Registered.png
Welcome to MBOS
We are focused on Autism and 
other neurological conditions
AUTISMINTRO2.png

*Chronic:  The term chronic is defined as a human health condition or disease with post-acute residual effects that are persistent or otherwise have long-lasting effects.  It is often applied when the course of the disease lasts for more than three months.

INTRODUCTION

An Intro...


Microbaric® Oxygen Systems LLC (MBOS) has developed what would appear to be the first practical and effective medical intervention for autism spectrum disorder (ASD). We have called this Microbaric® Oxygen Therapy (MBO2).

​

Pilot studies with five preteens and teenagers have shown this therapy to be beneficial for all subjects in the trial across all symptoms presented. In some cases, these benefits enabled the children to progress from all but severely autistic to mildly autistic in approximately 18 months with no regression over 7 years of follow-up. Using our protocol, MBO2 was administered for a maximum of five one-hour treatments per week in the home by the parents, typically the mother, on a schedule that fit with the family’s day-to-day activities.

​

From all aspects, this approach has promise to provide the efficacious, time-efficient, and cost-effective intervention that has been sought for decades. If MBO2 is to become the standard of care for ASD around the world, however, controlled trials to current medical standards must be conducted and reviewed by the FDA, MHRA and other government regulatory authorities.

In addition, our new equipment designs that will improve user friendliness and safety must be completed and receive regulatory clearance.

​

We are working on all of this now - information is here to share what we are doing.  If you are a research foundation that can help with the study, or an impact investor that can help us accelerate progress then please contact us.  

Our 2nd Newsletter!!

Our recent update for quick consumption...

Screenshot 2020-04-16 at 16.13.19.png
Oxygen Dose Response

After our hypothesis paper was published, we've been invited to submit further paper into a different journal on oxygen dose response.  Our experience in oxygen based medicine gives us a unique knowledge and perspective to write this.  Our work in treating neurological issues potentially opens a whole new field of research and application of oxygen to improve health.

iu-16_edited.jpg
A Collaboration

We are pleased to have started working with the Brainwave Center, leaders in neurofeedback and QEEG brain mapping.  Together we can explore and better understand how Microbaric oxygen is changing brain function, and see how the activity changes visually!  

Screenshot 2020-02-27 at 17.02.42.png
Profound and Lasting Change

At MBOS we are working to improve the outcome and quality of life for those significantly affected by Autism.  It is a growing challenge with limited options for many who are heavily impacted.  Drugs and/or psychotherapy have not provided an adequate solution across the broad spectrum of symptoms - they do not address the underlying biological cause.  We have been working privately on a limited basis with great results so far- we are now trying to bring this to market and make it generally available.

40M+

Total WW Diagnoses of Autism (2018)

1:59

2018 Diagnosis rate of children aged 8 with Autism

(Source : CDC April 27,2018)

Improvement in Autism evaluation (as measured by ATEC* for Subject 1.

(*ATEC - See ATEC Overview)

For More Information

01

Caregivers & Individuals

02

Clinicians & Researchers

03

Investors and Funding

What we are doing to win the battle with Autism

Clinical Trials To Get Regulatory Approvals

We are focused on establishing gold standard double-blind trials to demonstrate efficacy and our ethical approach.  We need research partners and funding.

Publishing Research & Clinical Findings

We have published a paper about our pilot studies which explains the history, treatment and results.  We are working on additional research papers to explore the biological basis of the therapy and more...

Delivering Frontline Therapy for Families

Our primary aim is to deliver Microbaric® Oxygen Therapy to the market and enable families to conduct treatment at home in a way that fits with family life.

SERVICES

CAREGIVER'S TESTIMONIAL FROM OUR PILOT STUDY

"It would take me months to make clear how this (Microbaric® Oxygen Therapy) has given me my children back.

I see so much in Subject 1, the little boy that I have been trying to save since he started showing signs of Autism around 2 years of age. Both of these boys have been on the vitamin regimen since very young because of chronic intestinal distress, speech delay (Subject 1 only), fright or flight (both boys had huge pupils). The vitamins slowly healed them. The huge pupils went away, and the tummy trouble did as well. We have been GF/CF (gluten free and casein free) for years and have been as organic as possible since 2002.

We have tried everything we could afford: Biomedical, chiropractic, accupressure, cranial sacchral therapy, hippotherapy, HBO2, speech therapy, occupational therapy, neuralign, and probably a few more that I cannot think of."

​

           - Mother and primary caregiver, 2 autistic brothers. 

​

STORIES
bottom of page